Source: MarketScreener

Constellation: MorphoSys : to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology (Form 6-K)

(marketscreener.com) MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology Company Announces Successful Completion of Tender Offer Moves Forward with Strategic Funding Partnership with Royalty Pharma MorphoSys...https://www.marketscreener.com/quote/stock/MORPHOSYS-AG-436425/news/MorphoSys-nbsp-to-Complete-Transformational-Acquisition-of-Constellation-Pharmaceuticals-Bolsteri-35865525/?utm_medium=RSS&utm_content=20210715

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
Jigar Raythatha's photo - President & CEO of Constellation

President & CEO

Jigar Raythatha

CEO Approval Rating

98/100

Read more